30.03.2012 17:50 Uhr, Quelle: Wallstreet online

DGAP-News: Raptor Pharmaceutical Corp. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis (deutsch)

Raptor Pharmaceutical Corp. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis Raptor Pharmaceutical Corp. 30.03.2012 …

Weiterlesen bei Wallstreet online